The document outlines an agenda for seminars focused on different sectors including energy, chemistry, materials, healthcare and life science, and smart human capital. The dates and focus areas of each seminar are listed. Additionally, the document provides statistics on assignments per sector from 2007 to 2017, with the top sectors being production food, FMCG, services, pharma and healthcare, and construction. It encourages business transformation and upcycling through these seminars.
A general company introduction,
UEG Medical Group is invested by UEG Hongkong, mainly focus on Dental Imaging, Surgical Navigation, Surgical equipment, Bioactive Wound Healing,
The company does business worldwide and has +300 employees, visit its website for more information: www.uegmedical.com
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...L.E.K. Consulting
L.E.K. Managing Director Alex Vadas spoke at a BDA workshop on "How to Mature Emerging Technologies into Companion Diagnostics?" See his presentation here.
The Laboratory Analytical and Life Science Instrument Industries: Looking Ahe...Bill Kelly
We take a look at the market hotspots to watch in 2018 for the Laboratory Analytical and Life Science Instrument Industries by giving you an overview of the market by the numbers and highlight specific industries including spectroscopy, chromatography, diagnostics, and laboratory software.
Humidification is Health: why is it worth and how should we humidify healthca...CAREL Industries S.p.A
Andrea Oscar Frisiero, Application Specialist - HVAC Commercial at Chillventa eSpecial 2020.
Relative humidity control is a key factor in the daily operations of an healthcare facility. This speech aims to start by explaining the importance of humidity for the patients' healing process, while then analyzing what are the main features that humidification systems properly design for healthcare should have.
Know more: healthcare.carel.com
A general company introduction,
UEG Medical Group is invested by UEG Hongkong, mainly focus on Dental Imaging, Surgical Navigation, Surgical equipment, Bioactive Wound Healing,
The company does business worldwide and has +300 employees, visit its website for more information: www.uegmedical.com
Opportunities and Challenges Associated with Novel Companion Diagnostic Techn...L.E.K. Consulting
L.E.K. Managing Director Alex Vadas spoke at a BDA workshop on "How to Mature Emerging Technologies into Companion Diagnostics?" See his presentation here.
The Laboratory Analytical and Life Science Instrument Industries: Looking Ahe...Bill Kelly
We take a look at the market hotspots to watch in 2018 for the Laboratory Analytical and Life Science Instrument Industries by giving you an overview of the market by the numbers and highlight specific industries including spectroscopy, chromatography, diagnostics, and laboratory software.
Humidification is Health: why is it worth and how should we humidify healthca...CAREL Industries S.p.A
Andrea Oscar Frisiero, Application Specialist - HVAC Commercial at Chillventa eSpecial 2020.
Relative humidity control is a key factor in the daily operations of an healthcare facility. This speech aims to start by explaining the importance of humidity for the patients' healing process, while then analyzing what are the main features that humidification systems properly design for healthcare should have.
Know more: healthcare.carel.com
Masters of the Industry at OIS@AAO 2016.
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD, CEO - Shire
Mike Ball, CEO - Alcon
Ashley McEvoy, Company Group Chairman - Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director - Versant Ventures
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec
William Meury, Chief Commercial Officer - Allergan
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
ScienceCloud: Collaborative Workflows in Biologics R&DBIOVIA
The life sciences industry has undergone dramatic changes and effective global collaboration has become a key success factor in this new age. BIOVIA is providing a hosted and comprehensive solution stack for externalized, collaborative research for pharma/biotech and CROs to address these new challenges. Recently we added the support for biologics data management and IP capture. In this talk we will present collaborative and comprehensive capabilities in antibody characterization and development: capabilities to analyze, annotate and predict developability as part of a framework that facilitates secure data sharing and collaboration.
The Exhaustive Study for “Dental Radiology Equipment Market” Research Report is added on Orbisresearch.com database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Paolo Liberati, Recuperator Technical Department - R&D and Andrea Pagan, CAREL Application Manager - HVAC Commercial at Chillventa eSpecial 2020.
Exploring CAREL's solutions for Air Handling Units able to ensure Health and Safety in critical applications, while remaining highly-efficient in terms of energy consumption.
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
Public Device & Biopharma Ophthalmology Company Showcase - pSividaHealthegy
Public Device & Biopharma Ophthalmology Company Showcase - pSivida at OIS@AAO 2016.
Presenter:
Nancy Lurker, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
PharmaLedger Official Presentation OverviewPharmaLedger
Download the Official PharmaLedger Project presentation, which introduces the project, its organisation and summarises the use cases.
In this downloadable presentation, you can find:
An introduction to the PharmaLedger project
PharmaLedger consortium
PharmaLedger objectives
Project organisation and governance
PharmaLedger platform overview
PharmaLedger selected use cases
Project roadmap
Value chain of use cases
Clinical Supply Chain Traceability use case summary
Supply Chain – Finished Goods Traceability use case summary
Supply Chain – E-Leaflet | EPI use case summary
Supply Chain – Anti-Counterfeiting use case summary
Clinical Trial – E-Consent use case summary
Healthdata – Medical Device IoT use case summary
Clinical Trial – Recruitment use case summary
Healthdata – Personalised Medicine use case summary
--
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Masters of the Industry at OIS@AAO 2016.
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
Participants:
Flemming Ornskov, MD, CEO - Shire
Mike Ball, CEO - Alcon
Ashley McEvoy, Company Group Chairman - Johnson & Johnson Vision Care
William J. Link, PhD, Managing Director - Versant Ventures
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec
William Meury, Chief Commercial Officer - Allergan
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
ScienceCloud: Collaborative Workflows in Biologics R&DBIOVIA
The life sciences industry has undergone dramatic changes and effective global collaboration has become a key success factor in this new age. BIOVIA is providing a hosted and comprehensive solution stack for externalized, collaborative research for pharma/biotech and CROs to address these new challenges. Recently we added the support for biologics data management and IP capture. In this talk we will present collaborative and comprehensive capabilities in antibody characterization and development: capabilities to analyze, annotate and predict developability as part of a framework that facilitates secure data sharing and collaboration.
The Exhaustive Study for “Dental Radiology Equipment Market” Research Report is added on Orbisresearch.com database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Paolo Liberati, Recuperator Technical Department - R&D and Andrea Pagan, CAREL Application Manager - HVAC Commercial at Chillventa eSpecial 2020.
Exploring CAREL's solutions for Air Handling Units able to ensure Health and Safety in critical applications, while remaining highly-efficient in terms of energy consumption.
ValGenesis Case Study With Scinopharm -Paperless Validation Software Solution ValGenesis
ValGenesis delivered a validated and qualified system in six weeks – the rapid implementation we needed. The system has been stable from the start, with little need for customer support calls, allowing us to focus on training and bringing on new users every week.”
— Steve Johnson, Director, Operations
Injectable Facility
ScinoPharm Taiwan, Ltd.
Public Device & Biopharma Ophthalmology Company Showcase - pSividaHealthegy
Public Device & Biopharma Ophthalmology Company Showcase - pSivida at OIS@AAO 2016.
Presenter:
Nancy Lurker, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
PharmaLedger Official Presentation OverviewPharmaLedger
Download the Official PharmaLedger Project presentation, which introduces the project, its organisation and summarises the use cases.
In this downloadable presentation, you can find:
An introduction to the PharmaLedger project
PharmaLedger consortium
PharmaLedger objectives
Project organisation and governance
PharmaLedger platform overview
PharmaLedger selected use cases
Project roadmap
Value chain of use cases
Clinical Supply Chain Traceability use case summary
Supply Chain – Finished Goods Traceability use case summary
Supply Chain – E-Leaflet | EPI use case summary
Supply Chain – Anti-Counterfeiting use case summary
Clinical Trial – E-Consent use case summary
Healthdata – Medical Device IoT use case summary
Clinical Trial – Recruitment use case summary
Healthdata – Personalised Medicine use case summary
--
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Optimizing the Output of Your Molecular Pathology LaboratoryJosh Forsythe
If you are a clinical lab looking to build or accelerate your NGS testing capability where do you start? The components of success can be overwhelming - planning, assay design, validation, clinical lab workflow, informatics, and interpretation.
During this one-hour webinar, BG Jones, SVP of Business Development for PierianDx, who has 23 years of experience in healthcare IT and genomics technology, will demonstrate how to pull it all together using "Actionable Intelligence" - a combination of machine learning and human expertise to achieve clinically actionable insights.
Presentation from OIS@ASCRS 2016
Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD
Company Presentations
Equinox | John Berdahl, MD, Founder & CEO
Presbyopia Therapies | Jim McCollum, Co-Founder
Stroma Medical | Doug Daniels, CEO
Eyenovia | Curt LaBelle, MD, Director
Wicab | Robert Beckman, President & COO
Convergence of medicines and consumer productsMichael Frank
Consumer products and medicines are becoming increasingly convergent. Innovation from the laboratory are accelerating into consumer technology, and vice versa.
Ebers and biogaran innovation challengeFacundo Noya
Ebers is a startup specialized in diabetic foot care and prevention. Our principal solution are smart insole that combines pressure, temperature and humidity measure with algorithm to alert early for any risk to diabetic patients.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
Digital Health: Company presentation by Eyal Gura, Co-Founder & CEO of Zebra Medical Vision at the NOAH Conference London 2019, 30-31 October, Old Billingsgate.
Our latest 3W event on ‘Digital transformation’ with keynote speaker Jo Caudron was a big success! Around 100 guests attended this network event organised by 3W.
Jo Caudron delivered a very informative insight on how digital disruption can influence companies.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
JMeter webinar - integration with InfluxDB and GrafanaRTTS
Watch this recorded webinar about real-time monitoring of application performance. See how to integrate Apache JMeter, the open-source leader in performance testing, with InfluxDB, the open-source time-series database, and Grafana, the open-source analytics and visualization application.
In this webinar, we will review the benefits of leveraging InfluxDB and Grafana when executing load tests and demonstrate how these tools are used to visualize performance metrics.
Length: 30 minutes
Session Overview
-------------------------------------------
During this webinar, we will cover the following topics while demonstrating the integrations of JMeter, InfluxDB and Grafana:
- What out-of-the-box solutions are available for real-time monitoring JMeter tests?
- What are the benefits of integrating InfluxDB and Grafana into the load testing stack?
- Which features are provided by Grafana?
- Demonstration of InfluxDB and Grafana using a practice web application
To view the webinar recording, go to:
https://www.rttsweb.com/jmeter-integration-webinar
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
"Impact of front-end architecture on development cost", Viktor TurskyiFwdays
I have heard many times that architecture is not important for the front-end. Also, many times I have seen how developers implement features on the front-end just following the standard rules for a framework and think that this is enough to successfully launch the project, and then the project fails. How to prevent this and what approach to choose? I have launched dozens of complex projects and during the talk we will analyze which approaches have worked for me and which have not.
State of ICS and IoT Cyber Threat Landscape Report 2024 previewPrayukth K V
The IoT and OT threat landscape report has been prepared by the Threat Research Team at Sectrio using data from Sectrio, cyber threat intelligence farming facilities spread across over 85 cities around the world. In addition, Sectrio also runs AI-based advanced threat and payload engagement facilities that serve as sinks to attract and engage sophisticated threat actors, and newer malware including new variants and latent threats that are at an earlier stage of development.
The latest edition of the OT/ICS and IoT security Threat Landscape Report 2024 also covers:
State of global ICS asset and network exposure
Sectoral targets and attacks as well as the cost of ransom
Global APT activity, AI usage, actor and tactic profiles, and implications
Rise in volumes of AI-powered cyberattacks
Major cyber events in 2024
Malware and malicious payload trends
Cyberattack types and targets
Vulnerability exploit attempts on CVEs
Attacks on counties – USA
Expansion of bot farms – how, where, and why
In-depth analysis of the cyber threat landscape across North America, South America, Europe, APAC, and the Middle East
Why are attacks on smart factories rising?
Cyber risk predictions
Axis of attacks – Europe
Systemic attacks in the Middle East
Download the full report from here:
https://sectrio.com/resources/ot-threat-landscape-reports/sectrio-releases-ot-ics-and-iot-security-threat-landscape-report-2024/
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Neuro-symbolic is not enough, we need neuro-*semantic*Frank van Harmelen
Neuro-symbolic (NeSy) AI is on the rise. However, simply machine learning on just any symbolic structure is not sufficient to really harvest the gains of NeSy. These will only be gained when the symbolic structures have an actual semantics. I give an operational definition of semantics as “predictable inference”.
All of this illustrated with link prediction over knowledge graphs, but the argument is general.
Neuro-symbolic is not enough, we need neuro-*semantic*
Roadshow:Health & Life Science
1.
2.
3.
4. 1. Vrijdag 16/06/2017: focus Energie
2. Vrijdag 29/09/2017: focus Chemie
3. Vrijdag 01/12/2017: focus Materialen
4. Vrijdag 02/02/2018: focus Healthcare & life Science
5. Vrijdag 20/04/2018 : focus Smart Human Capital
Upcycle your Business Transformation
5. 14%
11%
12%
10%
10%
9%
9%
7%
5%
4%
3%
3%
2% 1%
Assignments per sector 2007 - 2017
Production food
FMCG
Production Non Food
Services
Pharma & Healthcare
Construction
ICT
Transport & Logistics
Bank & Insurances
Energy
Automotive
Chemistry
Government
Aviation & Aerospace
6.
7.
8.
9.
10. We are XPErts by nature
Farmareus Pfizer stopt onderzoek naar
alzheimer- en parkinsonmedicijnen
Na een reorganisatie bij Pfizer stopt het bedrijf de zoektocht naar nieuwe
medicijnen voor de behandeling van alzheimer en parkinson. Dat heeft
Pfizer zelf bekendgemaakt. Het vrijgekomen budget zal volgens het bedrijf
in ander onderzoek geïnvesteerd worden.
11. Help our life-science partners,
improve quality of life by providing the
expertise they require to develop the
drugs, products and support their
customers and patients need.
OUR MISSION
12. XPE Pharma &
Science Belgian
Footprint
300 XPErts
+ 30 nationalities
Clients in Pharma, Biotech, Medical
Devices, Diagnostics, Laboratories,
Food and Beverage, Veterinary,
Healthcare environment
Offices in Wavre & Brussels
Global Competence Center in Cluj
(Romania)
0
50
100
150
200
250
300
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Number of consultants
Launch
13. Fields of XPErtise combined with our Services
STAFFING & CONSULTANCY PROJECT MANAGEMENT & DELIVERY
Technical
Clinical
Medical
EXPERT
SOURCING
OUTSOURCING
SERVICES
Sales &
Marketing
PERMANENT
PLACEMENT
14. XPE experts
XPE expertise
Discovery
phase
Preclinical
research
Research
director
Clinical
studies
Study
manager, CRA,
Data manager,
Statistician,
Medical writer,
Project nurses
Scientific
writing,
publications,
eTMF
management
Submission
and
approval
Regulatory
affairs
Manager,
publishers
RA writing
Pricing and
reimburse-
ment
Market
access
manager
Observational
studies
Manu-
facturing
Validation,
engineer, QA
Officer, Lab
technician,
Supply chain
manager
QA system
management
Go to
market
Sales rep,
Marketing
manager,
Medical science
liaison
Salesforce
outsourcing,
After sales/
Healthcare
Nurses, Elderly
care
Patient support
solutions
Experts & expertise for each phase in the
lifecycle of a drug or medical device
TRANSVERSAL: TRAINING, QUALITY MANAGEMENT, IM & IT, TRAINING SOLUTIONS
15. Adherence to treatment
guidelines for ovarian cancer is
correlated with improved survival
rates.
XPE provides psychological and
adherence training at a patient’s
home.
OVARIAN CANCER
16. About 1.7 to 5 billion cases of
diarrhea occur per year. It is the
second most common cause of
death in children younger than 5.
XPE participated developing a
vaccine to prevent Rotavirus:
• developing clinical studies
protocol,
• writing articles for healthcare
professionals,
• creating presentation
materials for congresses.
DIARRHEA
17. The average fatality rate of Ebola
virus is around 50%. Case fatality
rates have varied from 25% to 90%
in past outbreaks.
XPE participated in the
development of a vaccine by
writing protocols for the clinical
study
EBOLA VIRUS
19. Develop &
renew expertise
Transformation
• From experts to expertise
• From staffing provider to consultancy and
project management leader
• Talent leadership
• From recruiter to digital marketeer
26. VITO CONVERTS IDEAS
INTO REALITY
VITO MAKES OUR ENVIRONMENT
HEALTHY AND SUSTAINABLE
FROM SCIENCE
TO APPLICATION
VITO SUPPORTS THESE
SUSTAINABLE
DEVELOPMENT GOALS
27. WE DE-RISK INNOVATION
FOR COMPANIES
WE CONNECT RESEARCH AND MARKET,
KNOWLEDGE AND BUSINESS
WE OFFER
SOLUTIONS
WORLDWIDE
28. WE MAKE FLANDERS AND THE
WORLD MORE SUSTAINABLE
HEALTH
MATERIALS
ENERGY
CHEMISTRY
LAND USE
33. INSIGHT IN
OUR EARTH
BETTER MANAGING RESOURCES
THANKS TO ADVANCED
ENVIRONMENTAL MONITORING
LAND - WATER - AIR
34. WE PROVIDE SOLUTIONS
WORLDWIDE
227 SCIENTIFIC PUBLICATIONS34 NATIONALITIES
MORE THAN 400 PATENTS
24 NEW
PATENTS EVERY
YEAR
> €170 MILLION TURNOVER
784 EMPLOYEES
76 SME’S
91 PHD’S AND POSTDOCS
Experts
Projects
Experts and Projects
SUSTAINABLE ENTREPRENEURAL INSPIRING CREATIVE
37. The VITO Tech Transfer Office builds cleantech ventures and
transfers technology for a more sustainable, circular economy.
We connect VITO & aspiring entrepreneurs to start & grow
businesses, that address the societal challenges of tomorrow.
Our quest is to identify, nurture, guide & close opportunities
with capacity to profitable growth & worldwide impact.
TECH TRANSFER TEAM – MISSION
41. VITO SPIN-OFFS & STARTUP LICENCES OVERVIEW
CO2-negative
building materials
Sustainable
thermal energy
systems
Privacy-compliant
patient monitoring
3D coating with
hard materials
Drone flight control
platform SW
Battery data
management SW
Atmospheric
plasma devices
Virtual cycling platform
for homebound elderly
3D backflush membranes
Soil pollutant
Monitoring & modelling
In 3D & over time
20172014
VITOFOAMPortal for mapping
air pollutant exposure
Retina (eye)
health monitoring
(pollution & dementia)
Titanium foam for implants
(partner in China)
Drone flight
Platform SW
42. International research & technology centre
Cleantech & sustainable innovation
Connecting partners & stakeholders
Bridging knowlegde, policy & business
Active Technology Transfer Office & Team
VITO – VISION ON TECHNOLOGY
ENERGY
MATERIALS
CHEMISTRY
HEALTH
LAND USE
45. A new vision on
Oxygen Therapy for
Hospitals
Keynote – Health & Life Science
02/02/2018
www.oxypoint.eu
46. First Oxypoint Commercial Innovation
The Econo-Comfort O2-Flowmeter
“More Comfort with less O2 spilling!”
6/02/2018 Oxypoint – confidential – Patent protected 51
47. Econo-Comfort O2-Flowmeter = Pneumatic
device
Combines 2 modes:
• Comfort mode (unique for hospitals)
• Continuous mode (standard in hospitals)
• USP:
• More comfort for the patient
• Less consumption (up to 75% less O2)
• ROI for the hospital: 3 to 4 years
6/02/2018 52Oxypoint – confidential – Patent protected
68. Conclusion
Health & Life Science
Highly regulated field and hospitals are slow adopters
Innovation
Promising future pipeline and interesting new tech. ecosystem
Governmental help
Very helpful innovation and growth subsidies
Idea: creating incentives for (hospital) clients to buy innovations
Employment
Phase 1 (past, self-sufficient small team) 2 FTE => 5 FTE
Phase 2 (future, post Series A Financing) 5 FTE => 10 FTE => 16 FTE
6/02/2018 73Oxypoint – confidential – Patent protected
72. • Energyville is a top research institute on sustainable energy system for large urban areas.
Energyville’s 300 researchers develop new technology, knowledge and methodologies, resulting in
new products and services, development of human capital, and science-based policy support from
local to global level.
79. Data processing and algorithms
Sensors and devices
Metering, monitoring devices and
sensors
Aerial and satellite data
Buildings and infrastructures, real time
and predictive climate data
Application generated
data
User and usage related content, context and
feedback data
INCREASING POWER OF DATA
87. VITO icons can be found on: Y:_StoresStore02BeeldDataLogo's__VITOIconen
VITO pictures can be found on: Y:_StoresStore02BeeldDataFoto
Future healthcare will tackle disease by moving away from a ‘one size fits all
approach’, by integrating data on the entire dynamic biological makeup of
each individual, as well as the lifestyle and environmental factors that
interact with this makeup to develop a complex and individual phenotype.
This integrated information will be used to identify the most appropriate
healthcare for individual citizens.
104. What we have now…
• A system challenged by ( at least) 5 disruptive forces
• The Greying patient ( and Provider…)
• The Lifestyle Epidemic
• The Information Revolution
• The Blessing and Curse of Technology
• The New Health Care Consumer ( and Provider…)
A Rosen, Executive Research
Brief, The Advisory Board, 2014
123. What we should have…
• A system that saves and fosters Health
• Collectively
• Personally
• Predictive
• Preventive
• And that supplies , when saving health fails, Care for
the diseased,of the highest possible quality
124. What is “Quality of Care”
‘The degree to which health services for individuals and populations
increase the likelihood of desired health outcomes and are consistent with
current professional knowledge’ (IOM)
= a worldwide challenge
125. What is “Quality of Care” ?
“Quality” contains various elements
• Effective
• Efficient
• Continuous
• Safe
• Patientcentered
• Timely
• Accessible
• Integrated
126. What we should have…
Bodenheimer & Sinsky, Ann Fam Med 2014;12:573-6
127.
128. How to maximize value for patients in the HC system
Volume-based Value-based
Payment FFS Outcome based
Incentive Volume Value
Focus Acute episodes Populations
Role of provider Single episodes Care continuum
Information Retrospective Real-time & predicitve
Leadership style Managerial
divisional/departemental
thinking
Thinking across organisation
129.
130. Belgian hospitalitis...
International comparison shows
– More acute hospital beds
– Many more psychiatric hospital beds
– More hospital admissions
– Longer hospitalisation stays
– More hospitalisation days / inhabitant
– More medical equipment & usage offering
...than the average European country
134. The Hospital of the Future is a Network
•Published on February 17, 2017185
Jeroen Tas
Chief Innovation & Strategy Officer at Philips
Connecting Care for Continuous Hlth
135.
136. Focus on CARE in
horizontal networks
Focus on specialisation
in clinical networks
140. But:
145
Braithwaite et al: Complexity Science in Healthcare. Aspirations, approaches,
applications and accomplishments. A White Paper. Australian Institute of
Health Innovation.
141. Traditional Systems
• Improvement by decomposing
performance and management
into component elements, and
subsequently recomposing it by
integrating the designed
solution for each element
• Characteristics:
• Ability to de- and recompose
the elements of the system;
“designed”
• Linearity, predictability, “dead”
• Can be complicated, but not
“complex”
• Power with authority and
resources to (re)design the
system
• Works well in automotive,
manufacturing, retail,…
CAS
• Can NOT be addressed thru
hierarchical de/recomposition!
• Characteristics:
• Non-linear & dynamic : system
behaviour may appear to be
random/chaotic
• Composed by individual agents
who’s behaviour is based on
physical, psychological, or social
rules rather than on demands of
the system
• Agents are often conflicting and
intelligent : the overall system
behaviour learns and adapts
• Hence may lead to self-
organisation : patterns emerge
rather than being designed
• No single point of control : no one
is in charge
144. Real challenges…
• Do we accept that “Healthcare” is ( or at least behaves
like) a CAS (Complex Adaptive System ) with it’s own
governing laws ?
• And, therefore, is in need for a longterm purpose
(“Ikigaï”) and framework design, and should allow for the
role of non-linear thinking? E.g., allowing for Serendipity
• If Integrated Care is that purpose, should the obvious
first step not be...(re)integration..?
• (Hence, “networking” is (only) a means, not a goal)
• Do we accept than, that : “collaboration”, “networking”,…
and therefore Healthcare, is foremost dependent on
human interaction (sometimes two are sufficient…)
big Pharma companies to partner with multiple other companies (start ups) to lead and/or execute leading projects
Vito doet onderzoek en ontwikkelt technologieën om de transitie te maken naar een duurzame maatschappij.
Die transitie naar duurzaam denken en handelen is dringend en essentieel voor ons voortbestaan.
<KLIK>
Onze kennis en technologische innovaties op het domein van energie, chemie, materialen, gezondheidstechnologie en landgebruik faciliteren de transitie naar een duurzame samenleving.
Maar, die transitie of dat veranderingsproces komt niet vanzelf. Om dat te realiseren is impact nodig. VITO zorgt voor die impact en versnelt de transitie naar een duurzame wereld.
Vito creëert die impact op drie manieren.
Vooreerst directe impact:
Door producten, diensten en adviezen te ontwikkelen die bedrijven en overheden ondersteunen in hun duurzame initiatieven.
We creëren ook indirecte impact:
Door de creatie van spin-offs en licentieovereenkomsten zodat duurzame technologieën en ideeën hun weg naar de markt vinden en schaalvergroting kunnen realiseren.
Tenslotte verricht VITO ook conceptueel onderzoek waarmee het overheden, bedrijven en andere stakeholders begeleidt om een systeemomslag te realiseren.
VITO’s onderzoeksagenda focust zich op de grote maatschappelijke uitdagingen van vandaag: klimaatverandering, voedselzekerheid, grondstoffen schaarste, duurzame energievoorziening en de toename en de vergrijzing van de wereldbevolking, dat laatste althans in ons deel van de wereld.
Op deze manier ondersteunt VITO niet alleen de toekomstvisie van Vlaanderen maar ook de Sustainable Development Goals van de Verenigde Naties. Om een reële maatschappelijke impact te kunnen realiseren moet vanaf de start van het onderzoek rekening gehouden worden met alle mogelijke aspecten die een belangrijke rol spelen in de transitie van de wetenschap naar toepassing in de maatschappij. Alleen zo realiseren we een systeemomslag.
In het innovatielandschap bekleedt VITO een specifieke positie, namelijk één die het toelaat om verschillende partijen samen te brengen in een duurzame waardeketen. Door bedrijven, overheden, consumenten en andere belanghebbenden in een vroeg stadium in het onderzoeksproces te betrekken, kunnen wij technologie haalbaar en rendabel maken.
Op die manier versterkt VITO het economisch weefsel in Vlaanderen en daarbuiten.
VITO ondersteunt bedrijven via licentie-overeenkomsten en tech-transfer overeenkomsten, en biedt hulp aan Vlaamse bedrijven om internationaal te groeien. Daarnaast zorgt de ontwikkeling van spin-offs voor directe en indirecte werkgelegenheid.
Bovendien is VITO een belangrijke partner voor de overheid. Om nieuwe regelvoering en wetgeving voor te bereiden doen overheden beroep op wetenschappelijk bewezen duurzaamheidsonderzoek. Het vereist een voortdurende uitwisseling van kennis en informatie over sectoren en waardenketens heen. VITO fungeert als een spil in de interactie tussen de verschillende spelers in de maatschappij en zo kunnen we de sociale weerstand bij de implementatie van innovaties beperken.
Vlaanderen is niet de enige regio die wil bouwen aan een duurzame maatschappij binnen een snel veranderende wereld. Het is de ingeslagen weg voor Vlaanderen, Europa en de gehele wereld. VITO’s doelstellingen zijn daarom ook relevant buiten Vlaanderen. Om onze missie van een versnelde duurzaamheidstransitie te realiseren, is samenwerking met wereldwijde partijen en overheden de sleutel tot succes.
Het energieonderzoek van VITO is gecentraliseerd in EnergyVille op de voormalige mijnsite in Genk-Waterschei. Energyville is een samenwerkingsverband tussen de VITO, de KUL , iMEC en de UHAsselt.
Energyville richt zich op energie-efficiëntie en integratie van hernieuwbare energie in een duurzame stedelijke omgeving. Het is naast een kenniscentrum ook een living lab, waar we innovatieve thermische en elektrische energiesystemen uittesten en de energienetten van de toekomst demonstreren.
Sustainable Energy Electrical storage solutions
Thermal energy solutions
Energy Systems & markets
Smart cities
Deep geothermal
Om een toekomst te creëren waarin de chemische industrie zowel efficient als duurzaam is, zoekt VITO naar alternatieven om fossiele grondstoffen te vervangen door (bio-gebaseerde) alternatieven. Zij introduceert process technologieën die minder grondstoffen gebruiken, minder energie vereisen en minder afval genereren.
Natuurlijke grondstoffen worden steeds schaarser en de prijsschommelingen zorgen voor onzekerheid. Met onze onderzoeksprojecten en demonstraties rond grondstoffenbeheer, kringloopsluiting en nieuwe businessmodellen werken we concrete, rendabele oplossingen uit. Circulaire economie is een echte economische omwenteling, en daarvoor willen wij de wetenschappelijke bouwstenen aanleveren.
Materials Circular economy strategies
Sustainable industrial processes
Waste to products
De gezondheidszorg in Vlaanderen staat onder druk. De kwaliteit is uitstekend, maar de toenemende kosten maken het systeem onhoudbaar. Inzetten op preventie en precieze diagnose is een deel van de oplossing. Met nieuwe applicaties, meetmethodes en biomerkers wil VITO in de toekomst zoveel mogelijk aandoeningen voorkomen of in een vroeg stadium opsporen.
Health Environment health & safety
4P – medicine
Met satellieten monitoren we het landgebruik, drones geven ons inzicht in de staat van onze landbouwgewassen, vliegtuigen monitoren onze luchtkwaliteit en met laserdata krijgen we een beeld van onze infrastructuur. We werken nauw samen met ondernemers en Europese onderzoekspartners, zoals het Europese Ruimtevaartagentschap (ESA). Ons doel: kennis over de aarde beschikbaar maken om globale kwesties aan te pakken, of het nu over voedselproductie of biodiversiteit gaat.
Smogalarm, droogte, verstening: de media staan er bol van. Kritische hulpbronnen zoals lucht, water en ruimte worden schaars. VITO brengt de situatie in kaart en voorspelt met geavanceerde modellen de beschikbaarheid en kwaliteit van hulpbronnen in de toekomst. “We reiken beleidsmakers en ondernemers monitoringtools aan voor een toekomstgericht hulpbronnenbeheer.”Land use Water management
Air management
Land management
Remote sensing
Vlaanderen is niet de enige regio die wil bouwen aan een duurzame maatschappij binnen een snel veranderende wereld. Het is de ingeslagen weg voor Vlaanderen, Europa en de gehele wereld. VITO’s doelstellingen zijn daarom ook relevant buiten Vlaanderen. Om onze missie van een versnelde duurzaamheidstransitie te realiseren, is samenwerking met wereldwijde partijen en overheden de sleutel tot succes.
Info re metrics:
idea fair: R2M = smartupmywater launch = BATAL
Co-creatie post cycle = De Ceuster/DCM
EIT Digital ALUMNI - 2x intake = Floravision & MeHealthX
YEAR participants – NEED UPDATE on nrs & output
UH-IMOB – Route2school
VITO TTO – list in 2017
ORW – NEED UPDATE on nrs & output
A84H – AAL = Ambient & Assited Living
Inspriation day – NEED LIST
UA – 6x ideas = Preventive medical monitoring – indoor/outdoor AQ monitoring – allergeen sensoren – ouderen tracken met 3D-vision – sensor-cities – gedrag & emoties quantificeren
EIT Raw Materials – NEED UPDATE from MAT
CLP – 2015 finalist = CO2-electrorefinery (Metin Bulut) - 2016 finalist = FARO360 (Koen Verrecht)
Toevoegen:
De gezondheidszorg in Vlaanderen staat onder druk. De kwaliteit is uitstekend, maar de toenemende kosten maken het systeem onhoudbaar. Inzetten op preventie en precieze diagnose is een deel van de oplossing. Met nieuwe applicaties, meetmethodes en biomerkers wil VITO in de toekomst zoveel mogelijk aandoeningen voorkomen of in een vroeg stadium opsporen.